Cargando…
Real-life data of hypoglycemic events in children and adolescents with type 1 diabetes
INTRODUCTION: Hypoglycemia composes an always present risk in the treatment of type 1 diabetes (T1D) and can be a fatal complication. Many studies on hypoglycemic events are based on self-reported data or focused on the aggregated time below range. We have processed continuous glucose monitoring (CG...
Autores principales: | Hill, Henrik, Klaar, Per, Espes, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533671/ https://www.ncbi.nlm.nih.gov/pubmed/37739421 http://dx.doi.org/10.1136/bmjdrc-2023-003485 |
Ejemplares similares
-
Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis
por: Grönberg, Annika, et al.
Publicado: (2022) -
Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later
por: Grönberg, Annika, et al.
Publicado: (2020) -
Risk of non-hypoglycemic agents for hypoglycemia-related hospitalization in patients with type 2 diabetes: a large-scale medical receipt database analysis
por: Horii, Takeshi, et al.
Publicado: (2023) -
Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK
por: Thalange, Nandu, et al.
Publicado: (2019) -
Real-world use of once-weekly semaglutide in patients with type 2 diabetes: pooled analysis of data from four SURE studies by baseline characteristic subgroups
por: Yale, Jean-François, et al.
Publicado: (2022)